TBRG Stock Analysis: Buy, Sell, or Hold?
TBRG - TruBridge, Inc. Common Stock
$15.65
1.01 (6.90%)
▲
5d:
+7.19%
30d:
-18.06%
90d:
-28.44%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When TBRG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TBRG trading at deep discount. Market pricing in -13.8% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: TBRG trading at deep discount. Market pricing in -13.8% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$45.20
Based on 13.3% avg growth
INTRINSIC VALUE TODAY
$28.07
44.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TBRG is currently trading at $15.65, which is considered slightly low relative to its 30-day fair value range of $15.12 to $19.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.6) compared to its historical average (8.7). Remarkably, the market is currently pricing in an annual earnings decline of 13.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TBRG is in a strong downtrend. Immediate support is located at $13.88, while resistance sits at $16.15. The stock is showing strong short-term momentum, up 6.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.67 (+44.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TBRG is in a strong downtrend. Immediate support is located at $13.88, while resistance sits at $16.15. The stock is showing strong short-term momentum, up 6.9% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.67 (+44.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$15.12 -
$19.15
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.9%)
- BULLISH: Trading 44.8% below Wall St target ($22.67)
Fair Price Analysis
30-Day Fair Range
$15.12 -
$19.15
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$13.88
Resistance Level
$16.15
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.56
Wall Street Target
$22.67
(+44.8%)
Revenue Growth (YoY)
1.7%
Earnings Growth (YoY)
-61.8%
Profit Margin
1.0%
Valuation Discount vs History
-13.8% cheaper
PE vs Historical
5.6 vs 8.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.8%
(market-implied from PE analysis)
1-Year Target
$14.09
(-10%)
2-Year Target
$12.68
(-19%)
3-Year Target
$11.41
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→9)
$17.84
(+14%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 22.5%)
$115.56
(+638%)
Base:
(SPY PE: 5.6, Growth: 22.5%)
$28.77
(+84%)
Bear:
(PE: 4.7, Growth: 22.5%)
$24.45
(+56%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (7x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Forward PE: 6.52 | Forward EPS (Implied): $2.36
Bull Case
$18.57
(+21%)
Analyst growth 15.0%, PE expands to 6.9
Base Case
$15.38
(0%)
Market implied 0.0%, PE stable at 6.5
Bear Case
$11.77
(-24%)
Severe decline -15.0%, PE contracts to 5.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.6 to 8.7
Stabilization Target:
$24.47
(+56.3%)
PE Expansion Potential:
+56.3%
Share & Embed Analysis
Last updated: April 02, 2026 9:33 AM ET
Data refreshes hourly during market hours. Next update: 10:33 AM
Data refreshes hourly during market hours. Next update: 10:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TBRG showing a specific setup today?
Insider Activity (6 Months)
16
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Pinetree Capital Ltd.
BUY
10000 shares
2025-12-03
Pinetree Capital Ltd.
BUY
45000 shares
2025-12-02
Pinetree Capital Ltd.
BUY
75000 shares
2025-12-01
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 61 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 66 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 53 HOLD |
